UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

Solving the crisis in psychopharmacological research: Cellular-membrane(s) pharmacology to the rescue?

Biomedicine & pharmacotherapy, 2020-10, Vol.130, p.110545, Article 110545

2020

Volltextzugriff (PDF)

The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (A[beta]) and colocalizes with deposited A[beta] in cerebral amyloid angiopathy

Neuropathology and applied neurobiology, 2016-04, Vol.42 (3), p.255

2016

Volltextzugriff (PDF)

The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy

Neuropathology and applied neurobiology, 2016-04, Vol.42 (3), p.255-272

2016

Volltextzugriff (PDF)

Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra

Neurobiology of aging, 2004-10, Vol.25 (9), p.1253-1262

2004

Volltextzugriff (PDF)

Anti-inflammatory effect by lentiviral-mediated overexpression of IL-10 or IL-1 receptor antagonist in rat glial cells and macrophages

Gene therapy, 2010-05, Vol.17 (5), p.662-671

2010

Volltextzugriff (PDF)

The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytes

Journal of Neural Transmission, 2006-05, Vol.113 (5), p.593-598

2006

Volltextzugriff (PDF)

The thiol antioxidant 1,2-dithiole-3-thione stimulates the expression of heat shock protein 70 in dopaminergic PC12 cells

Neuroscience letters, 2007-04, Vol.416 (1), p.76-81

2007

Volltextzugriff (PDF)

Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency

Brain research, 1997-10, Vol.770 (1), p.123-130

1997

Volltextzugriff (PDF)

Neuroprotection for Parkinson's disease: a new approach for a new millennium

Expert opinion on investigational drugs, 2001-10, Vol.10 (10), p.1855-1868

2001

Volltextzugriff (PDF)

Regulation of the activity of striatal cholinergic neurons by dopamine

Neuroscience, 1992, Vol.47 (4), p.755-770

1992

Volltextzugriff (PDF)

Changed distribution pattern of the constitutive rather than the inducible HSP70 chaperone in neuromelanin-containing neurones of the Parkinsonian midbrain

Neuropathology and applied neurobiology, 2006-04, Vol.32 (2), p.157-169

2006

Volltextzugriff (PDF)

Detoxication enzyme inducers modify cytokine production in rat mixed glial cells

Journal of neuroimmunology, 2005-09, Vol.166 (1), p.132-143

2005

Volltextzugriff (PDF)

Anethole dithiolethione, a putative neuroprotectant, increases intracellular and extracellular glutathione levels during starvation of cultured astroglial cells

Naunyn-Schmiedeberg's archives of pharmacology, 1998-12, Vol.358 (6), p.616-622

1998

Volltextzugriff (PDF)

2.429 Tissue transglutaminase is activated and redistributed to ER-derived granules in neuroblastoma cells treated with the PD-mimicking neurotoxin MPP

Parkinsonism & related disorders, 2007, Vol.13, p.S135-S135

2007

Volltextzugriff (PDF)

Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology

Brain Research Reviews, 2007-12, Vol.56 (2), p.322-330

2007

Volltextzugriff (PDF)

The Effect of Pramipexole Therapy on Balance Disorder and Fall Risk in Parkinson’s Disease at Early Stage: Clinical and Posturographic Assessment

ISRN neurology, 2012, Vol.2012, p.320607-7

2012

Volltextzugriff (PDF)

The blood clotting F actor XIIIa forms unique complexes with amyloid‐beta ( A β) and colocalizes with deposited A β in cerebral amyloid angiopathy

Neuropathology and applied neurobiology, 2016-04, Vol.42 (3), p.255-272

2016

Volltextzugriff (PDF)

The Human Frontal Lobes and Frontal Network Systems: An Evolutionary, Clinical, and Treatment Perspective

ISRN neurology, 2013, Vol.2013, p.892459-34

2013

Volltextzugriff (PDF)

Effect of Chronic L-Dopa or Melatonin Treatments after Dopamine Deafferentation in Rats: Dyskinesia, Motor Performance, and Cytological Analysis

ISRN neurology, 2012-02, Vol.2012, p.360379-16

2012

Volltextzugriff (PDF)

Neuroinflammation in Parkinson’s patients and MPTP-treated mice is not restricted to the nigrostriatal system: Microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb

Experimental gerontology, 2007-08, Vol.42 (8), p.762-771

2007

Volltextzugriff (PDF)

Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease

NeuroImage (Orlando, Fla.), 2005-07, Vol.26 (4), p.1150-1158

2005

Volltextzugriff (PDF)

Drug treatment of Parkinson’s disease: Time for phase II

Biochemical pharmacology, 2000-05, Vol.59 (9), p.1023-1031

2000

Volltextzugriff (PDF)

The dopamine D 1 agonist SKF 81297 and the dopamine D 2 agonist LY 171555 act synergistically to stimulate motor behavior of 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine‐lesioned parkinsonian rhesus monkeys

Movement disorders, 1994-11, Vol.9 (6), p.664-672

1994

Volltextzugriff (PDF)

The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958

Behavioural pharmacology, 1999-03, Vol.10 (2), p.175-182

1999

Volltextzugriff (PDF)

D-2 dopamine autoreceptor selective drugs: Do they really exist?

Life Sciences, 1990, Vol.47 (5), p.361-376

1990

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(116)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Animals
(58)
Science & Technology
(51)
Life Sciences & Biomedicine
(50)
Rats
(43)
Biological And Medical Sciences
(39)
Male
(35)
Neurosciences & Neurology
(29)
Neurosciences
(26)
Parkinson's Disease
(23)
Medical Sciences
(21)
Rats, Wistar
(21)
Fundamental And Applied Biological Sciences. Psychology
(19)
Humans
(17)
Pharmacology & Pharmacy
(16)
Pharmacology. Drug Treatments
(16)
Cells, Cultured
(15)
Vertebrates: Nervous System And Sense Organs
(15)
Dopamine - Metabolism
(14)
Neuropharmacology
(14)
In Vitro Techniques
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Solving the crisis in psychopharmacological research: Cellular-membrane(s) pharmacology to the rescue?

The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (A[beta]) and colocalizes with deposited A[beta] in cerebral amyloid angiopathy

The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy

Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra

Anti-inflammatory effect by lentiviral-mediated overexpression of IL-10 or IL-1 receptor antagonist in rat glial cells and macrophages

The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytes

The thiol antioxidant 1,2-dithiole-3-thione stimulates the expression of heat shock protein 70 in dopaminergic PC12 cells

Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency

Neuroprotection for Parkinson's disease: a new approach for a new millennium

Regulation of the activity of striatal cholinergic neurons by dopamine

Changed distribution pattern of the constitutive rather than the inducible HSP70 chaperone in neuromelanin-containing neurones of the Parkinsonian midbrain

Detoxication enzyme inducers modify cytokine production in rat mixed glial cells

Anethole dithiolethione, a putative neuroprotectant, increases intracellular and extracellular glutathione levels during starvation of cultured astroglial cells

2.429 Tissue transglutaminase is activated and redistributed to ER-derived granules in neuroblastoma cells treated with the PD-mimicking neurotoxin MPP

Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology

The Effect of Pramipexole Therapy on Balance Disorder and Fall Risk in Parkinson’s Disease at Early Stage: Clinical and Posturographic Assessment

The blood clotting F actor XIIIa forms unique complexes with amyloid‐beta ( A β) and colocalizes with deposited A β in cerebral amyloid angiopathy

The Human Frontal Lobes and Frontal Network Systems: An Evolutionary, Clinical, and Treatment Perspective

Effect of Chronic L-Dopa or Melatonin Treatments after Dopamine Deafferentation in Rats: Dyskinesia, Motor Performance, and Cytological Analysis

Neuroinflammation in Parkinson’s patients and MPTP-treated mice is not restricted to the nigrostriatal system: Microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb

Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease

Drug treatment of Parkinson’s disease: Time for phase II

The dopamine D 1 agonist SKF 81297 and the dopamine D 2 agonist LY 171555 act synergistically to stimulate motor behavior of 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine‐lesioned parkinsonian rhesus monkeys

The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958

D-2 dopamine autoreceptor selective drugs: Do they really exist?

Suchergebnisse filtern